US-based medical device company Presidio Medical has raised $30m in a funding round led by Invus Opportunities.
The round was also joined by the company’s existing investor Action Potential Venture Capital.
Presidio Medical plans to use the funds for the development of its neuromodulation technology platform to treat chronic pain.
South San Francisco-based company also plans to expand the platform application to include additional indications.
Presidio Medical’s neuromodulation technology platform offers pain relief across a spectrum of pain types where conventional treatment has failed.
